373 results on '"Lambers Heerspink, Hiddo J"'
Search Results
2. Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
3. The role of venous capacity in fluid retention with endothelin A antagonism: Mathematical modelling of the RADAR trial.
4. Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors
5. Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial.
6. Diseases of Renal Microcirculation: Diabetic Nephropathy
7. Urine Albumin-Creatinine Ratio Versus Albumin Excretion for Albuminuria Staging: A Prospective Longitudinal Cohort Study
8. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
9. A Meta-analysis of the Association of Estimated GFR, Albuminuria, Age, Race, and Sex With Acute Kidney Injury
10. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial)
11. Fibroblast Growth Factor 23 and the Antiproteinuric Response to Dietary Sodium Restriction During Renin-Angiotensin-Aldosterone System Blockade
12. GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials
13. GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials
14. Visit-to-Visit Variability in Blood Pressure and Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Nephropathy: A Post Hoc Analysis From the RENAAL Study and the Irbesartan Diabetic Nephropathy Trial
15. Increased Levels of Urinary Albumin: A Cardiovascular Risk Factor and a Target for Treatment
16. Estimated Albumin Excretion Rate Versus Urine Albumin-Creatinine Ratio for the Assessment of Albuminuria: A Diagnostic Test Study From the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study
17. Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)
18. Additional file 1 of Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults
19. Therapeutic Approaches in Lowering Albuminuria: Travels Along the Renin-Angiotensin-Aldosterone-System Pathway
20. The association of albuminuria and high-sensitivity C-reactive protein with the efficacy of HMG-coenzyme A reductase inhibitors for cardiovascular event prevention
21. Albuminuria
22. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression
23. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine
24. Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes
25. Relevance of correction for drift and day-to-day variation in cystatin C measurement: a post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort
26. Diseases of Renal Microcirculation: Diabetic Nephropathy
27. Pathogenesis, Pathophysiology, and Treatment of Diabetic Nephropathy
28. Contributors
29. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
30. Bilirubin and Progression of Nephropathy in Type 2 Diabetes: A Post Hoc Analysis of RENAAL With Independent Replication in IDNT
31. Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease
32. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
33. The effect of RAAS blockade on the progression of diabetic nephropathy
34. Cardiovascular disease in patients with chronic kidney disease
35. Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
36. Age and Sex Effects on the Single- and Multiple-dose Safety and Pharmacokinetics of the New Rennin Inhibitor ACT-178882
37. Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
38. Isolated microalbuminuria indicates a poor medical prognosis
39. Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
40. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort
41. Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy
42. Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
43. Performance of MDRD study and CKD-EPI equations for long-term follow-up of nondiabetic patients with chronic kidney disease
44. Salt intake in kidney disease—a missed therapeutic opportunity?
45. High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate
46. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
47. DIABETES: ROADMAP: the road to renoprotection?
48. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
49. Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34: 703–709
50. Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.